BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1592885)

  • 1. Recovery of parathyroid hormone secretion during correction of tumor-associated hypercalcemia.
    Body JJ; Dumon JC; Seraj F; Cleeren A
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1385-8. PubMed ID: 1592885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of malignancy-associated hypercalcemia with YM175, a new bisphosphonate: elevated threshold for parathyroid hormone secretion in hypercalcemic patients.
    Fukumoto S; Matsumoto T; Takebe K; Onaya T; Eto S; Nawata H; Ogata E
    J Clin Endocrinol Metab; 1994 Jul; 79(1):165-70. PubMed ID: 8027221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating PTH and PTHrP levels before and after treatment of tumor induced hypercalcemia with Pamidronate Disodium (APD).
    Grill V; Murray RM; Ho PW; Santamaria JD; Pitt P; Potts C; Jerums G; Martin TJ
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1468-70. PubMed ID: 1592895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating PTHrP concentrations in tumor-induced hypercalcemia: influence on the response to bisphosphonate and changes after therapy.
    Body JJ; Dumon JC; Thirion M; Cleeren A
    J Bone Miner Res; 1993 Jun; 8(6):701-6. PubMed ID: 8328312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
    Brossard JH; Roy L; Lepage R; Gascon-Barré M; D'Amour P
    Miner Electrolyte Metab; 1997; 23(1):25-32. PubMed ID: 9058366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
    Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
    J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hysteresis in the relationship between serum ionized calcium and intact parathyroid hormone during recovery from induced hyper- and hypocalcemia in normal humans.
    Conlin PR; Fajtova VT; Mortensen RM; LeBoff MS; Brown EM
    J Clin Endocrinol Metab; 1989 Sep; 69(3):593-9. PubMed ID: 2760172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
    Jansson S; Tisell LE; Lindstedt G; Lundberg PA
    Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
    Budayr AA; Zysset E; Jenzer A; Thiébaud D; Ammann P; Rizzoli R; Jaquet-Müller F; Bonjour JP; Gertz B; Burckhardt P
    J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperprolactinemia caused by lactation and pituitary adenomas is associated with altered serum calcium, phosphate, parathyroid hormone (PTH), and PTH-related peptide levels.
    Kovacs CS; Chik CL
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3036-42. PubMed ID: 7559893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone (PTH)-related protein, PTH, and 1,25-dihydroxyvitamin D in dogs with cancer-associated hypercalcemia.
    Rosol TJ; Nagode LA; Couto CG; Hammer AS; Chew DJ; Peterson JL; Ayl RD; Steinmeyer CL; Capen CC
    Endocrinology; 1992 Sep; 131(3):1157-64. PubMed ID: 1505457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma intact parathyroid hormone (PTH) and PTH-related peptide in familial benign hypercalcemia: greater responsiveness to endogenous PTH than in primary hyperparathyroidism.
    Firek AF; Kao PC; Heath H
    J Clin Endocrinol Metab; 1991 Mar; 72(3):541-6. PubMed ID: 1997510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy.
    Rizzoli R; Thiébaud D; Bundred N; Pecherstorfer M; Herrmann Z; Huss HJ; Rückert F; Manegold C; Tubiana-Hulin M; Steinhauer EU; Degardin M; Thürlimann B; Clemens MR; Eghbali H; Body JJ
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3545-50. PubMed ID: 10522993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The efficacy and safety of intravenous bisphosphonates in the treatment of primary hyperparathyroidism complicated by hypercalcemia crisis].
    Han GY; Wang O; Xing XP; Meng XW; Lian XL; Guan H; Ye W; Xia WB; Li M; Jiang Y; Hu YY; Liu HC; Cui QC
    Zhonghua Nei Ke Za Zhi; 2009 Sep; 48(9):729-33. PubMed ID: 20079207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disodium pamidronate (APD) in therapy of hypercalcemia in primary hyperparathyroidism].
    Kotzmann H; Svoboda T; Bernecker P; Clodi M; Woloszczuk W; Niederle B; Waldhäusl W; Luger A
    Wien Klin Wochenschr; 1994; 106(13):422-5. PubMed ID: 8091766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of intact parathyroid hormone in patients with calcium metabolism disorders].
    Birkeland KI; Falch JA; Gautvik KM; Gjestvang FT; Holst N; Haug E
    Tidsskr Nor Laegeforen; 1991 Jun; 111(15):1840-4. PubMed ID: 1853314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
    Bro S; Brandi L; Olgaard K
    Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A reduced PTH response to hypocalcemia after a short period of hypercalcemia: a study in dogs.
    Sánchez J; Aguilera-Tejero E; Estepa JC; Almadén Y; Rodríguez M; Felsenfeld AJ
    Kidney Int Suppl; 1996 Dec; 57():S18-22. PubMed ID: 8941917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive escape from parathyroid suppression: a common phenomenon in primary hyperparathyroidism (a calcium clamp study).
    Sørensen HA; Schwarz P; Hyldstrup L; Transbøl I
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):309-15. PubMed ID: 8187293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy.
    Fraser WD; Logue FC; Gallacher SJ; O'Reilly DS; Beastall GH; Ralston SH; Boyle IT
    Bone Miner; 1991 Feb; 12(2):113-21. PubMed ID: 1849762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.